Sample | Peak No | Identified Compound | tR (min) | % of total | Quality (%) |
---|---|---|---|---|---|
MR | 2 | 2,2-Dimethoxybutane | 9.516 | 1.49 | 74 |
3 | 3,5-dihydroxy-6-methyl-2,3-dihydropyran-4-one | 23.310 | 0.76 | 83 | |
4 | Cyclohexasiloxane | 27.558 | 0.79 | 93 | |
5 | 2,4-Di-tert-butylphenol | 33.320 | 1.13 | 97 | |
6 | (E)-2,6-Dimethoxy-4-(prop-1-en-1-yl)phenol | 37.932 | 1.06 | 95 | |
7 | n-Hexadecanoic acid | 43.192 | 4.51 | 99 | |
8 | n-Hexadecanoic acid, ethyl ester | 43.865 | 0.73 | 96 | |
9 | (3aR,8aR,9aR)-8a-methyl-5-methylene-3-[(1-methylolpropylamino)methyl]-3a,4,4a,6,7,8,9,9a-octahydro-3H-benzo[f]benzofuran-2-one | 45.839 | 0.66 | 93 | |
10 | (9Z,12Z)-octadeca-9,12-dienoic acid | 46.487 | 1.30 | 99 | |
11 | Ethyl linolate | 47.027 | 1.12 | 97 | |
12 | Hexadecanamide | 47.383 | 0.30 | 92 | |
13 | 9-Octadecanamide | 50.531 | 4.81 | 97 | |
14 | Erucylamide | 57.031 | 8.97 | 99 | |
15 | Vitamin E | 64.452 | 1.78 | 91 | |
16 | 5-(4-Nitrophenyl)-1,3,4-oxadiazol-2(5H)-one | 70.772 | 13.88 | 86 | |
IR | 2 | Acetic acid ethyl ester | 6.136 | 0.62 | 72 |
3 | 2,2-Dimethoxybutane | 9.516 | 0.64 | 74 | |
4 | 3,5-dihydroxy-6-methyl-2,3-dihydropyran-4-one | 23.270 | 1.88 | 97 | |
5 | 4-Vinylphenol | 25.430 | 0.88 | 87 | |
6 | Cyclohexasiloxane | 27.557 | 0.63 | 91 | |
7 | 2-Methoxy-4-vinylphenol | 28.313 | 0.70 | 95 | |
8 | 2,6-dimethoxyphenol | 29.255 | 0.49 | 97 | |
9 | 2-Cyclohexylpiperidine | 29.957 | 0.79 | 72 | |
10 | 2,4-Di-tert-butylphenol | 33.319 | 0.86 | 95 | |
11 | (E)-2,6-Dimethoxy-4-(prop-1-en-1-yl)phenol | 37.922 | 0.81 | 98 | |
12 | n-Hexadecanoic acid | 43.187 | 3.04 | 99 | |
13 | Hexadecanamide | 47.377 | 0.27 | 91 | |
14 | 9-Octadecanamide | 50.529 | 2.60 | 98 | |
15 | Erucylamide | 57.029 | 4.63 | 99 | |
16 | 5-(4-Nitrophenyl)-1,3,4-oxadiazol-2(5H)-one | 69.718 | 2.81 | 86 |